BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 26712589)

  • 1. Pain management in head and neck cancer patients undergoing chemo-radiotherapy: Clinical practical recommendations.
    Mirabile A; Airoldi M; Ripamonti C; Bolner A; Murphy B; Russi E; Numico G; Licitra L; Bossi P
    Crit Rev Oncol Hematol; 2016 Mar; 99():100-6. PubMed ID: 26712589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucositis in head and neck cancer patients treated with radiotherapy and systemic therapies: Literature review and consensus statements.
    De Sanctis V; Bossi P; Sanguineti G; Trippa F; Ferrari D; Bacigalupo A; Ripamonti CI; Buglione M; Pergolizzi S; Langendjik JA; Murphy B; Raber-Durlacher J; Russi EG; Lalla RV
    Crit Rev Oncol Hematol; 2016 Apr; 100():147-66. PubMed ID: 26947812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sepsis in head and neck cancer patients treated with chemotherapy and radiation: Literature review and consensus.
    Mirabile A; Numico G; Russi EG; Bossi P; Crippa F; Bacigalupo A; De Sanctis V; Musso S; Merlotti A; Ghi MG; Merlano MC; Licitra L; Moretto F; Denaro N; Caspiani O; Buglione M; Pergolizzi S; Cascio A; Bernier J; Raber-Durlacher J; Vermorken JB; Murphy B; Ranieri MV; Dellinger RP
    Crit Rev Oncol Hematol; 2015 Aug; 95(2):191-213. PubMed ID: 25818202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute skin toxicity management in head and neck cancer patients treated with radiotherapy and chemotherapy or EGFR inhibitors: Literature review and consensus.
    Russi EG; Moretto F; Rampino M; Benasso M; Bacigalupo A; De Sanctis V; Numico G; Bossi P; Buglione M; Lombardo A; Airoldi M; Merlano MC; Licitra L; Denaro N; Pergolizzi S; Pinto C; Bensadoun RJ; Girolomoni G; Langendijk JA
    Crit Rev Oncol Hematol; 2015 Oct; 96(1):167-82. PubMed ID: 26187236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Xerostomia and trismus (Part 2). Literature review and consensus statement.
    Buglione M; Cavagnini R; Di Rosario F; Maddalo M; Vassalli L; Grisanti S; Salgarello S; Orlandi E; Bossi P; Majorana A; Gastaldi G; Berruti A; Trippa F; Nicolai P; Barasch A; Russi EG; Raber-Durlacher J; Murphy B; Magrini SM
    Crit Rev Oncol Hematol; 2016 Jun; 102():47-54. PubMed ID: 27061883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysphagia in head and neck cancer patients treated with radiotherapy and systemic therapies: Literature review and consensus.
    Schindler A; Denaro N; Russi EG; Pizzorni N; Bossi P; Merlotti A; Spadola Bissetti M; Numico G; Gava A; Orlandi E; Caspiani O; Buglione M; Alterio D; Bacigalupo A; De Sanctis V; Pavanato G; Ripamonti C; Merlano MC; Licitra L; Sanguineti G; Langendijk JA; Murphy B
    Crit Rev Oncol Hematol; 2015 Nov; 96(2):372-84. PubMed ID: 26141260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Dental pathologies and osteoradionecrosis (Part 1) literature review and consensus statement.
    Buglione M; Cavagnini R; Di Rosario F; Sottocornola L; Maddalo M; Vassalli L; Grisanti S; Salgarello S; Orlandi E; Paganelli C; Majorana A; Gastaldi G; Bossi P; Berruti A; Pavanato G; Nicolai P; Maroldi R; Barasch A; Russi EG; Raber-Durlacher J; Murphy B; Magrini SM
    Crit Rev Oncol Hematol; 2016 Jan; 97():131-42. PubMed ID: 26318095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral mucositis in head and neck cancer: Evidence-based management and review of clinical trial data.
    Blakaj A; Bonomi M; Gamez ME; Blakaj DM
    Oral Oncol; 2019 Aug; 95():29-34. PubMed ID: 31345391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SAMITAL® improves chemo/radiotherapy-induced oral mucositis in patients with head and neck cancer: results of a randomized, placebo-controlled, single-blind Phase II study.
    Pawar D; Neve RS; Kalgane S; Riva A; Bombardelli E; Ronchi M; Petrangolini G; Morazzoni P
    Support Care Cancer; 2013 Mar; 21(3):827-34. PubMed ID: 22945882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rebamipide gargle in preventive management of chemo-radiotherapy induced oral mucositis.
    Chaitanya B; Pai KM; Yathiraj PH; Fernandes D; Chhaparwal Y
    Oral Oncol; 2017 Sep; 72():179-182. PubMed ID: 28797456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic review of basic oral care for the management of oral mucositis in cancer patients.
    McGuire DB; Fulton JS; Park J; Brown CG; Correa ME; Eilers J; Elad S; Gibson F; Oberle-Edwards LK; Bowen J; Lalla RV;
    Support Care Cancer; 2013 Nov; 21(11):3165-77. PubMed ID: 24018908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer treatment-induced oral mucositis: a critical review.
    Rodríguez-Caballero A; Torres-Lagares D; Robles-García M; Pachón-Ibáñez J; González-Padilla D; Gutiérrez-Pérez JL
    Int J Oral Maxillofac Surg; 2012 Feb; 41(2):225-38. PubMed ID: 22071451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase II study of HMB/Arg/Gln against oral mucositis induced by chemoradiotherapy for patients with head and neck cancer.
    Yokota T; Hamauchi S; Yoshida Y; Yurikusa T; Suzuki M; Yamashita A; Ogawa H; Onoe T; Mori K; Onitsuka T
    Support Care Cancer; 2018 Sep; 26(9):3241-3248. PubMed ID: 29627862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective assessment of oral mucositis and its impact on quality of life and patient-reported outcomes during radiotherapy for head and neck cancer.
    Franco P; Martini S; Di Muzio J; Cavallin C; Arcadipane F; Rampino M; Ostellino O; Pecorari G; Garzino Demo P; Fasolis M; Airoldi M; Ricardi U
    Med Oncol; 2017 May; 34(5):81. PubMed ID: 28386836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of chemo/radiation-induced oral mucositis in patients with head and neck cancer: A review of the current literature.
    Moslemi D; Nokhandani AM; Otaghsaraei MT; Moghadamnia Y; Kazemi S; Moghadamnia AA
    Radiother Oncol; 2016 Jul; 120(1):13-20. PubMed ID: 27113797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The timing of the appearance of oral mucositis induced by concurrent chemoradiotherapy with S-1 for head and neck cancer].
    Yonekita H; Takase H; Ogata K; Futagami K; Nomoto S; Yoshimitsu K; Nakagawa T; Tokunaga S
    Gan To Kagaku Ryoho; 2014 Dec; 41(13):2571-5. PubMed ID: 25596050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Confounding factors associated with oral mucositis assessment in patients receiving chemoradiotherapy for head and neck cancer.
    Chung YL; Pui NNM
    Support Care Cancer; 2017 Sep; 25(9):2743-2751. PubMed ID: 28353040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spectrum of fungal infection in head and neck cancer patients on chemoradiotherapy.
    Singh GK; Capoor MR; Nair D; Bhowmik KT
    J Egypt Natl Canc Inst; 2017 Mar; 29(1):33-37. PubMed ID: 28258917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. World Workshop on Oral Medicine VII: Non-opioid pain management of head and neck chemo/radiation-induced mucositis: A systematic review.
    Christoforou J; Karasneh J; Manfredi M; Dave B; Walker JS; Dios PD; Epstein J; Kumar N; Glick M; Lockhart PB; Patton LL
    Oral Dis; 2019 Jun; 25 Suppl 1():182-192. PubMed ID: 30811811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fentanyl pectin nasal spray as treatment for incident predictable breakthrough pain (BTP) in oral mucositis induced by chemoradiotherapy in head and neck cancer.
    Bossi P; Locati L; Bergamini C; Mirabile A; Granata R; Imbimbo M; Resteghini C; Licitra L
    Oral Oncol; 2014 Sep; 50(9):884-7. PubMed ID: 25001894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.